title: Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells.
abstract: Sphingosine 1-phosphate (S1P) is involved in the local inflammatory response within the intestinal muscularis, which has been suggested to play a major role in the pathogenesis of postoperative ileus. The aim of the present study was to elucidate the role of S1P and the molecular mechanisms underlying regulation of inflammatory mediators in primary cultured rat intestinal smooth muscle (RISM) cells. Although our experimental data clearly show the mediatory role of sphingosine kinase (SK)-derived S1P in the TNF-alpha and the LPS induced activation of NF-kB, exogenously added S1P failed to trigger this transcription factor. Instead, exogenous S1P induced early growth response-1 (Egr-1), which was reported to play a proinflammatory role in postoperative ileus. Using RNA interference we found that Egr-1 is required primarily for S1P-induced expression of IL-1 and COX2. Conversely, IL-6 expression following S1P treatment was mediated by STAT3 (signal transducer and activator of transcription-3). In addition our data indicate that the proinflammatory effect of S1P is mediated by its receptors S1P(1-3) and requires activation of MAP-kinases. In conclusion, Egr-1 and STAT3 cooperatively mediate S1P-induced inflammatory responses in RISM cells, providing novel targets for attenuation of postoperative ileus.
authors.affiliation: Kekulé-Institute for Organic Chemistry and Biochemistry, University Bonn, Germany.
authors.forename: Mihaela
authors.initials: M
authors.lastname: Gurgui
authors.forename: Roland
authors.initials: R
authors.lastname: Broere
authors.forename: Jörg C
authors.initials: JC
authors.lastname: Kalff
authors.forename: Gerhild
authors.initials: G
authors.lastname: van Echten-Deckert
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000378:metabolism; D051766:Early Growth Response Protein 1 / Q000235:genetics / Q000378:metabolism; D018836:Inflammation Mediators / Q000378:metabolism*; D007375:Interleukin-1 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007422:Intestines / Q000166:cytology; D008246:Lysophospholipids / Q000494:pharmacology*; D008297:Male; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics / Q000378:metabolism; D034622:RNA Interference; D020733:RNA, Small Cytoplasmic / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D049349:Receptors, Lysosphingolipid / Q000235:genetics / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000494:pharmacology; D000099157:Sphingosine Kinase
chemical_list: D051546:Cyclooxygenase 2; D051766:Early Growth Response Protein 1; D018836:Inflammation Mediators; D007375:Interleukin-1; D015850:Interleukin-6; D008246:Lysophospholipids; D016328:NF-kappa B; D017853:Phosphotransferases (Alcohol Group Acceptor); D020733:RNA, Small Cytoplasmic; D049349:Receptors, Lysosphingolipid; D050796:STAT3 Transcription Factor; D013110:Sphingosine; D014409:Tumor Necrosis Factor-alpha; D000099157:Sphingosine Kinase; C494088:Stat3 protein, rat; C060506:sphingosine 1-phosphate